| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Jul―13 |
Pre-existing Comorbidities as Potential Risk Modifiers for New-Onset Myocarditis and Pericarditis following mRNA COVID-19 Vaccination in Males Aged 18-30 in the United States: A Disproportionality Analysis using VAERS Spontaneous Reporting Data |
Mohammed Salah Salem, Yola Moride, Bernard Bégaud |
| 2 |
[GO] |
2023―Mrz―24 |
Digoxin and Standard-of-Care Therapy for Heart Failure Patients with COVID-19: Analysis of Data from the US Military Health System (MHS) Data Repository |
Amanda L. Banaag, Harvey B. Pollard, Tracey P. Koehlmoos |
| 3 |
[GO] |
2023―Feb―17 |
Myopericarditis Associated with the Novavax COVID-19 Vaccine (NVX-CoV2373): A Retrospective Analysis of Individual Case Safety Reports from VigiBase |
Diego Macías Saint-Gerons, María Teresa Ibarz, José Luis Castro, Jaume Forés-Martos, Rafael Tabarés-Seisdedos |
| 4 |
[GO] |
2022―Nov―03 |
Trends in the Use of Sedative-Hypnotics, Opioids, and Neuromuscular Blockers in Hospitalized Patients During the COVID-19 Pandemic: Observational Retrospective Study |
Manuel E. Machado-Duque, Andrés Gaviria-Mendoza, Luis Fernando Valladales-Restrepo, Juan Pablo Albanés-Beltrán, Jorge Enrique Machado-Alba |
| 5 |
[GO] |
2022―Sep―15 |
Impact of the COVID-19 Pandemic on Patterns of Prescription Opioid Use: A Retrospective Cohort Study of Adults Without a Cancer Diagnosis Initiating Opioids Using Administrative Claims Data |
Anne-Marie Castilloux, Genaro Castillon, Yola Moride |
| 6 |
[GO] |
2022―Jul―09 |
Hypothesis-Agnostic Network-Based Analysis of Real-World Data Suggests Ondansetron is Associated with Lower COVID-19 Any Cause Mortality |
Gregory M. Miller, J. Austin Ellis, Rangaprasad Sarangarajan, Amay Parikh, Leonardo O. Rodrigues, Can Bruce, Nischal Mahaveer Chand, Steven R. Smith, Kris Richardson, Raymond Vazquez, Michael A. Kiebish, Chandran Haneesh, Elder Granger, Judy Holtz, Jacob Hinkle, Niven R. Narain, Bret Goodpaster, Jeremy C. Smith, Daniel S. Lupu |
| 7 |
[GO] |
2022―Apr―06 |
Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) |
Ying Zhao, Jingru Zhang, Kai Zheng, Sydney Thai, Ross J. Simpson, Alan C. Kinlaw, Yang Xu, Jingkai Wei, Xiangli Cui, John B Buse, Til Stürmer, Tiansheng Wang |
| 8 |
[GO] |
2022―Feb―10 |
Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database |
Luis H. Martín, María Sainz-Gil, Ester Navarro-García, Inés Salado-Valdivieso, Rosario Sanz-Fadrique |
| 9 |
[GO] |
2021―Feb―11 |
Pharmacotherapy Management for COVID-19 and Cardiac Safety: A Data Mining Approach for Pharmacovigilance Evidence from the FDA Adverse Event Reporting System (FAERS) |
Jing Yuan, Minghui Li, Yiqun Yu, Tai-Ying Lee, Gang Lv, Bing Han, Xiaoqiang Xiang, Z. Kevin Lu |
|
